Literature DB >> 1574164

Spectrum of neural-tube defects in 34 infants prenatally exposed to antiepileptic drugs.

D Lindhout1, J G Omtzigt, M C Cornel.   

Abstract

We analyzed the spectrum of neural-tube defects associated with maternal exposure to antiepileptic drugs (AEDs) and the possible contribution of familial and genetic factors to epilepsy or neural-tube defects. No specific association with maternal family history of neural-tube defects or epilepsy was seen. The ratio of spina bifida to anencephaly (33:1) suggested a specific association with caudal defects. Hydrocephaly was documented in at least 21 cases. Other midline defects, all associated with valproate (VPA), were hypospadias (two), hypertelorism (two), partial agenesis of corpus callosum, agenesis of septum pellucidum with lissencephaly of medial sides of occipital lobes, Dandy-Walker anomaly, and ventricular septal defect. This study shows that most neural-tube defects following maternal VPA use are severe open defects. They are frequently complicated by hydrocephaly and other midline defects. Prenatal diagnosis is possible.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1574164

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

Review 1.  Teenagers with epilepsy.

Authors:  R E Appleton; B G Neville
Journal:  Arch Dis Child       Date:  1999-07       Impact factor: 3.791

2.  Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register.

Authors:  J Morrow; A Russell; E Guthrie; L Parsons; I Robertson; R Waddell; B Irwin; R C McGivern; P J Morrison; J Craig
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09-12       Impact factor: 10.154

3.  Neuroimaging of prenatal drug exposure.

Authors:  Diana L Dow-Edwards; Helene Benveniste; Marylou Behnke; Emmalee S Bandstra; Lynn T Singer; Yasmin L Hurd; L R Stanford
Journal:  Neurotoxicol Teratol       Date:  2006 May-Jun       Impact factor: 3.763

4.  Simultaneous folate intake may prevent adverse effect of valproic acid on neurulating nervous system.

Authors:  Ahmet Sukru Umur; Mehmet Selcuki; Adem Bursali; Nurcan Umur; Burcu Kara; H Seda Vatansever; Yusuf Kurtulus Duransoy
Journal:  Childs Nerv Syst       Date:  2012-01-14       Impact factor: 1.475

5.  Effects of lacosamide "a novel antiepileptic drug" in the early stages of chicken embryo development.

Authors:  Mesut Mete; Beyhan Gurcu; Fatih Collu; Ulkun Unlu Unsal; Yusuf Kurtulus Duransoy; Mehmet Ibrahim Tuglu; Mehmet Selcuki
Journal:  Childs Nerv Syst       Date:  2016-07-29       Impact factor: 1.475

6.  Women and epilepsy.

Authors:  Sunila E O'Connor; Mary L Zupanc
Journal:  J Pediatr Pharmacol Ther       Date:  2009-10

Review 7.  Do lamotrigine and levetiracetam solve the problem of using sodium valproate in women with epilepsy?

Authors:  John J Craig
Journal:  Obstet Med       Date:  2012-02-20

Review 8.  Management of epilepsy during pregnancy.

Authors:  Dina Battino; Torbjörn Tomson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 9.  Valproic acid use in psychiatry: issues in treating women of reproductive age.

Authors:  D Kennedy; G Koren
Journal:  J Psychiatry Neurosci       Date:  1998-09       Impact factor: 6.186

10.  Risk of hypospadias in newborn infants exposed to valproic acid during the first trimester of pregnancy: a case-control study in Spain.

Authors:  Elvira Rodríguez-Pinilla; Consuelo Mejías; David Prieto-Merino; Paloma Fernández; María L Martínez-Frías
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.